You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML, ALL, MSD

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Pyronaridine Tetraphosphate
  • Guediawaye GOL SUD, Dakar, Senegal
    Dalal Jamm Hospital
Nov 23, 2022

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

Recruiting
  • AML
  • +4 more
  • CD123-CAR T
  • +4 more
  • Memphis, Tennessee
  • +1 more
May 10, 2022

ALL, Adult, AML, Adult Trial (BN104)

Not yet recruiting
  • ALL, Adult
  • AML, Adult
  • (no location specified)
Sep 19, 2023

Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

Recruiting
  • Acute Myeloid Leukemia
  • Tucson, Arizona
  • +8 more
Jan 3, 2023

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Acute Myeloid Leukemia (AML) Trial in United States (Gilteritinib, Ivosidenib, Enasidenib)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2023

Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,

Completed
Has Results
  • Lymphoblastic Leukemia, Acute, Childhood
  • Myelogenous Leukemia, Acute, Childhood
  • Los Angeles, California
  • +10 more
Mar 24, 2022

Latin American Real-world Study in Acute Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
    • Montería, Colombia
      Oncomedica SA
    Jan 5, 2022

    Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

    Recruiting
    • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
    • Duarte, California
    • +12 more
    Jan 4, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia
    • +2 more
    • CliniMacs TCR alpha-beta-Biotin system
    • Los Angeles, California
    • +9 more
    Feb 10, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Houston, Texas
    • +5 more
    May 31, 2022

    Relapsed Pediatric ALL, Relapsed Pediatric AML, Refractory Acute Myeloid Leukemia Trial in Kansas City (Daunorubicin)

    Recruiting
    • Relapsed Pediatric ALL
    • +3 more
    • Kansas City, Missouri
      Children's Mercy Hospital
    Jul 1, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Atlanta, New York (MRX-2843)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Jul 6, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

    Terminated
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Boston, Massachusetts
    • +5 more
    Jun 11, 2021

    Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
    • +2 more
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital & Research Center
    Apr 4, 2022

    Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)

    Available
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • (no location specified)
    Mar 28, 2022

    Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

    Recruiting
    • Leukemia, Acute
    • +3 more
    • Palliative Care Visits
    • Charlottesville, Virginia
      University of Virginia
    Apr 28, 2022

    Changing Over Time of Ascorbic Acid After Chemotherapy

    Active, not recruiting
    • Leukemia (Both ALL and AML)
    • +2 more
    • blood withdrawn
    • Maastricht, Limburg, Netherlands
      MUMC+
    Sep 23, 2021

    Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using

    Recruiting
    • Relapsed Pediatric ALL
    • +2 more
    • In Vitro T cells depletion using CliniMCAS system
    • Shanghai, China
      Shanghai Children's Medical Center
    Sep 28, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Jan 18, 2023